InVivo Therapeutics Holdings PE Ratio 2012-2023 | NVIVQ
Current and historical p/e ratio for InVivo Therapeutics Holdings (NVIVQ) from 2012 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. InVivo Therapeutics Holdings PE ratio as of January 13, 2026 is 0.00.
| InVivo Therapeutics Holdings PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-07-19 | 0.37 | 0.00 | |
| 2023-09-30 | 1.12 | $-0.87 | 0.00 |
| 2023-06-30 | 1.35 | $-1.98 | 0.00 |
| 2023-03-31 | 1.06 | $-3.95 | 0.00 |
| 2022-12-31 | 2.35 | $-5.89 | 0.00 |
| 2022-09-30 | 4.29 | $-8.14 | 0.00 |
| 2022-06-30 | 4.05 | $-7.91 | 0.00 |
| 2022-03-31 | 8.75 | $-7.69 | 0.00 |
| 2021-12-31 | 11.50 | $-7.75 | 0.00 |
| 2021-09-30 | 17.50 | $-5.50 | 0.00 |
| 2021-06-30 | 18.50 | $-15.50 | 0.00 |
| 2021-03-31 | 24.75 | $-26.00 | 0.00 |
| 2020-12-31 | 20.25 | $-85.75 | 0.00 |
| 2020-09-30 | 35.50 | $-85.75 | 0.00 |
| 2020-06-30 | 39.50 | $-291.72 | 0.00 |
| 2020-03-31 | 42.25 | $-534.72 | 0.00 |
| 2019-12-31 | 165.00 | $-683.18 | 0.00 |
| 2019-09-30 | 375.00 | $-683.18 | 0.00 |
| 2019-06-30 | 555.00 | $-780.78 | 0.00 |
| 2019-03-31 | 1162.50 | $-6,141.14 | 0.00 |
| 2018-12-31 | 1132.50 | $-8,438.44 | 0.00 |
| 2018-09-30 | 1515.00 | $-10,878.38 | 0.00 |
| 2018-06-30 | 1275.00 | $-15,818.32 | 0.00 |
| 2018-03-31 | 10125.00 | $-13,956.46 | 0.00 |
| 2017-12-31 | 14437.50 | $-15,202.70 | 0.00 |
| 2017-09-30 | 27187.50 | $-15,953.45 | 0.00 |
| 2017-06-30 | 50625.00 | $-14,264.27 | 0.00 |
| 2017-03-31 | 75937.50 | $-13,513.51 | 0.00 |
| 2016-12-31 | 78750.00 | $-14,264.26 | 0.00 |
| 2016-09-30 | 127500.00 | $-14,264.26 | 0.00 |
| 2016-06-30 | 108375.00 | $-12,387.39 | 0.00 |
| 2016-03-31 | 130875.00 | $-16,704.20 | 0.00 |
| 2015-12-31 | 135000.00 | $-24,211.71 | 0.00 |
| 2015-09-30 | 161625.00 | $-27,777.78 | 0.00 |
| 2015-06-30 | 302812.00 | $-26,839.34 | 0.00 |
| 2015-03-31 | 222750.00 | $-22,522.52 | 0.00 |
| 2014-12-31 | 99000.00 | $-15,765.77 | 0.00 |
| 2014-09-30 | 42000.00 | $-14,264.26 | 0.00 |
| 2014-06-30 | 78000.00 | $-18,768.77 | 0.00 |
| 2014-03-31 | 132000.00 | $-30,780.78 | 0.00 |
| 2013-12-31 | 172500.00 | $-40,540.53 | 0.00 |
| 2013-09-30 | 107250.00 | $-45,045.04 | 0.00 |
| 2013-06-30 | 309750.00 | $-31,531.52 | 0.00 |
| 2013-03-31 | 179250.00 | $-14,264.26 | 0.00 |
| 2012-12-31 | 130500.00 | $4,504.50 | 28.97 |
| 2012-09-30 | 116250.00 | $-36,786.79 | 0.00 |
| 2012-06-30 | 171750.00 | $-40,540.54 | 0.00 |
| 2012-03-31 | 186000.00 | $-45,045.04 | 0.00 |
| 2011-12-31 | 206250.00 | $-48,798.80 | 0.00 |
| 2011-09-30 | 49500.00 | $2,252.25 | 21.98 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.000B |
| InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.733B | 24.98 |
| EssilorLuxottica (ESLOY) | France | $149.439B | 0.00 |
| Boston Scientific (BSX) | United States | $141.899B | 32.45 |
| Stryker (SYK) | United States | $138.196B | 27.44 |
| Medtronic (MDT) | Ireland | $124.291B | 17.22 |
| Medline (MDLN) | United States | $56.122B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Agilent Technologies (A) | United States | $41.955B | 26.52 |
| GE HealthCare Technologies (GEHC) | United States | $39.585B | 18.93 |
| ResMed (RMD) | United States | $37.629B | 26.04 |
| Koninklijke Philips (PHG) | Netherlands | $28.695B | 18.74 |
| Terumo (TRUMY) | Japan | $21.868B | 24.62 |
| Insulet (PODD) | United States | $19.595B | 60.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.124B | 11.30 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.309B | 0.00 |
| Baxter (BAX) | United States | $10.358B | 8.36 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.713B | 31.33 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| BillionToOne (BLLN) | United States | $4.538B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.475B | 13.63 |
| Haemonetics (HAE) | United States | $3.881B | 17.27 |
| Envista Holdings (NVST) | United States | $3.844B | 22.06 |
| ICU Medical (ICUI) | United States | $3.732B | 23.70 |
| Prestige Consumer Healthcare (PBH) | United States | $3.140B | 14.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.266B | 14.57 |
| Perrigo (PRGO) | Ireland | $2.056B | 5.15 |
| Neogen (NEOG) | United States | $2.038B | 44.62 |
| LeMaitre Vascular (LMAT) | United States | $1.902B | 38.28 |
| AtriCure (ATRC) | United States | $1.871B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.845B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.819B | 79.73 |
| Phibro Animal Health (PAHC) | United States | $1.614B | 16.13 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.496B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.436B | 20.78 |
| Kestra Medical Technologies (KMTS) | United States | $1.366B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.157B | 343.43 |
| Capricor Therapeutics (CAPR) | United States | $1.121B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.044B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.007B | 0.00 |
| InMode (INMD) | Israel | $0.916B | 10.35 |
| Omeros (OMER) | United States | $0.909B | 0.00 |
| CeriBell (CBLL) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.840B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.558B | 15.12 |
| Cresco Labs (CRLBF) | United States | $0.497B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.489B | 0.00 |
| Brainsway (BWAY) | Israel | $0.474B | 80.63 |
| Canopy Growth (CGC) | Canada | $0.453B | 0.00 |
| SNDL (SNDL) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.436B | 0.00 |
| Evolus (EOLS) | United States | $0.374B | 0.00 |
| Quanterix (QTRX) | United States | $0.344B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.293B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TerrAscend (TSNDF) | Canada | $0.259B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.241B | 142.00 |
| High Tide (HITI) | Canada | $0.238B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.213B | 0.00 |
| Accendra Health (ACH) | United States | $0.207B | 2.08 |
| Vireo Growth (VREOF) | United States | $0.204B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.192B | 16.92 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Exagen (XGN) | United States | $0.135B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.75 |
| Biote (BTMD) | United States | $0.115B | 5.02 |
| MacroGenics (MGNX) | United States | $0.113B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.65 |
| Sharps Technology (STSS) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.048B | 34.92 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Veru (VERU) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.47 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |